Thermo Fisher Scientific agreed to sell its microbiology business to Astorg for about $1.08 billion, including cash and a $50 million seller note. The transaction is a portfolio simplification move that should provide capital while reshaping the company’s business mix. The announcement is constructive for Thermo Fisher but broadly routine for the market.
Thermo Fisher Scientific agreed to sell its microbiology business to Astorg for about $1.08 billion, including cash and a $50 million seller note. The transaction is a portfolio simplification move that should provide capital while reshaping the company’s business mix. The announcement is constructive for Thermo Fisher but broadly routine for the market.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
